E10.3493 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, bilateral

Name of the Condition

• Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, bilateral

Summary

Type 1 diabetes mellitus is a chronic autoimmune condition characterized by insufficient insulin production. When associated with severe nonproliferative diabetic retinopathy without macular edema, it indicates advanced retinal damage due to prolonged hyperglycemia. This stage involves widespread microaneurysms, intraretinal hemorrhages, venous beading, and intraretinal microvascular abnormalities without neovascularization or macular fluid accumulation. Both eyes are affected, requiring comprehensive monitoring to prevent progression to proliferative disease or vision loss.

Causes

Type 1 diabetes arises from an autoimmune response that destroys insulin-producing beta cells in the pancreas. Severe nonproliferative diabetic retinopathy without macular edema develops as a result of sustained high blood glucose levels, which damage retinal blood vessels over time. The exact mechanisms involve oxidative stress, inflammation, and vascular changes specific to ocular structures, leading to progressive retinal ischemia and structural damage without macular involvement in both eyes.

Risk Factors

• Poor glycemic control
• Duration of diabetes (longer exposure increases risk)
• Hypertension
• Dyslipidemia
• Smoking
• Genetic predisposition to diabetic eye disease

Symptoms

• Blurred vision
• Floaters
• Difficulty seeing in low light
• Reduced color perception
• Asymptomatic in early stages (often detected via screening)

Diagnosis

Diagnosis involves a comprehensive eye examination, including dilated funduscopy, optical coherence tomography (OCT) to rule out macular edema, and fluorescein angiography to assess retinal vascular changes. Blood glucose and HbA1c levels are evaluated to confirm diabetes control. Bilateral involvement is confirmed by examining both eyes, with documentation of severe nonproliferative changes without macular edema.

Treatment Options

• Intensive glycemic control to slow retinopathy progression
• Blood pressure and lipid management
• Regular eye screenings (every 6–12 months)
• Laser photocoagulation if high-risk features develop
• Anti-VEGF therapy if macular edema occurs (not applicable here but noted for context)

Prognosis and Follow-Up

With strict glycemic control and regular monitoring, progression to proliferative retinopathy or vision loss can be delayed. Bilateral involvement requires ongoing surveillance to detect changes in either eye. Follow-up intervals depend on disease severity and response to treatment, with more frequent visits if retinopathy advances.

Complications

• Progression to proliferative diabetic retinopathy
• Macular edema (if develops)
• Vision impairment or blindness
• Increased risk of cataracts and glaucoma

Lifestyle & Prevention

• Maintain target blood glucose levels
• Control blood pressure and cholesterol
• Avoid smoking
• Regular physical activity
• Annual dilated eye exams for early detection

When to Seek Professional Help

Seek immediate care if you experience sudden vision changes, floaters, or vision loss, as these may indicate progression to proliferative disease or macular edema. Routine follow-ups with an ophthalmologist are essential for bilateral cases.

Tips for Medical Coders

Document the bilateral nature of the severe nonproliferative diabetic retinopathy without macular edema clearly in the medical record. Ensure the absence of macular edema and proliferative changes is specified, as these distinctions impact coding accuracy. Verify that the diagnosis aligns with clinical findings and that both eyes are documented as affected.